Omnipaque 350 mg/mL

Omnipaque 350 mg/mL is an iodinated contrast media used for enhancing visibility during imaging procedures. This intravenous solution is designed for diagnostic imaging, including CT scans and angiography. It contains iohexol, a non-ionic contrast agent.

Omnipaque 350 mg/mL is primarily used to improve the clarity of images during various diagnostic imaging procedures. It is commonly administered intravenously to enhance the visibility of blood vessels, organs, and tissues. This contrast media is often used in computed tomography (CT) scans and angiography to help healthcare professionals obtain detailed images for accurate diagnosis.

When administered, Omnipaque 350 mg/mL may cause a temporary warm sensation or a metallic taste in the mouth. Some individuals might experience mild nausea or a brief headache. These effects are generally short-lived and subside quickly. Severe reactions are rare but can occur, and immediate medical attention should be sought if any unusual symptoms arise.

Omnipaque 350 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast media. It is important to inform healthcare providers about any known allergies or medical conditions before administration. Pregnant women and individuals with kidney problems should discuss the risks and benefits with their healthcare provider.

Omnipaque 350 mg/mL may interact with certain medications, including those that affect kidney function. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances that affect kidney function should be avoided before and after administration.